Iproteos Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Iproteos General Information

Description

Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The company's therapy specializes in the research and development of third-generation drugs, such as protein-protein interactions (PPIs), enabling medical professionals to treat schizophrenia, epilepsy, pediatric cancer and other neurological disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain
+34 934 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Iproteos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 28-May-2020 00.000 Completed Generating Revenue
7. Early Stage VC (Series A) 15-Jul-2018 00.000 Completed Generating Revenue
6. Grant 29-May-2017 00.000 Completed Generating Revenue
5. Seed Round 25-Oct-2016 00.000 00.000 Completed Pre-Clinical Trials
4. Equity Crowdfunding 26-Sep-2016 00000 00000 Completed Pre-Clinical Trials
3. Equity Crowdfunding 01-Nov-2014 00000 00000 Completed Startup
2. Grant 01-Jan-2014 $686K $144K Completed Startup
1. Capitalization 01-Jan-2012 $144K $144K Completed Startup
To view Iproteos’s complete valuation and funding history, request access »

Iproteos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The
Drug Discovery
Barcelona, Spain
00.000
000000&0 00.000

0000000

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
0000000000 0 000.00

00000000

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000000000000
Concord, MA
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iproteos Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Minoryx Therapeutics Venture Capital-Backed Barcelona, Spain 00 000.00 0000000000 0 000.00
00000000 000000000 Venture Capital-Backed Concord, MA 0 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
0000000 0000000000 Formerly VC-backed La Jolla, CA 00 00000 00000000 00000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000 - 000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Iproteos Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ASCIL Biopharm Other Minority 000 0000 000000 0
CAIXA CAPITAL RISC Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Kinled Holding Venture Capital Minority 000 0000 000000 0
Ministerio de Economía, Industria y Competitividad Government 000 0000 000000 0
To view Iproteos’s complete investors history, request access »